Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the effectiveness and safety of matched targeted therapies in people with relapsed or metastatic cancer in phase I, II and III trials.

This is a protocol.

Published:

29 October 2021

Authors:

Kazmi F, Shrestha N, Booth S, Dodwell D, Aroldi F, Foord T, Nicholson BD, Heesen P, Lord S, Yeoh K-W, Blagden S

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Kazmi F, Shrestha N, Booth S, Dodwell D, Aroldi F, Foord T, Nicholson BD, Heesen P, Lord S, Yeoh K-W, Blagden S. Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD014872. DOI: 10.1002/14651858.CD014872.